These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19749653)

  • 1. Should we admit patients with haematological malignancy to intensive care?
    Jones C; Hewson R; Ramessur S
    Br J Hosp Med (Lond); 2009 Sep; 70(9):544. PubMed ID: 19749653
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive care for patients with medical complications of haematological malignancy: is it worth it?
    Hinds CJ; Martin R; Quinton P
    Schweiz Med Wochenschr; 1998 Sep; 128(39):1467-73. PubMed ID: 9793166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A response to 'Incidence and outcome of critical illness amongst hospitalised patients with haematological malignance: a prospective observational study of ward and intensive care unit based care'.
    Szawarski P
    Anaesthesia; 2005 Sep; 60(9):945; author reply 945-6. PubMed ID: 16115277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hematologic and oncologic emergencies].
    von Bergwelt-Baildon M; Böll B; Shimabukuro-Vornhagen A; Kochanek M
    Med Klin Intensivmed Notfmed; 2013 Apr; 108(3):184-90. PubMed ID: 23455441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy.
    Hill QA
    Blood Rev; 2010 Jan; 24(1):17-25. PubMed ID: 19913962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive care of haematological patients.
    Magid T; Haase N; Andersen JS; Nielsen OJ; Bonde J
    Dan Med J; 2012 Mar; 59(3):A4395. PubMed ID: 22381090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care.
    Gordon AC; Oakervee HE; Kaya B; Thomas JM; Barnett MJ; Rohatiner AZ; Lister TA; Cavenagh JD; Hinds CJ
    Anaesthesia; 2005 Apr; 60(4):340-7. PubMed ID: 15766336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treat haematology patients as long as possible].
    Huijgens PC
    Ned Tijdschr Geneeskd; 2010; 154(51-52):A2882. PubMed ID: 21211076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infections in hemato-oncology patients in intensive care. An interdisciplinary challenge].
    Kochanek M; von Bergwelt-Baildon M; Shimabukuro-Vornhagen A
    Med Klin Intensivmed Notfmed; 2013 Apr; 108(3):197-202. PubMed ID: 23525488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and patterns of infections in patients with underlying haematological malignancies admitted to intensive care.
    José RJ; Pfeffer PE; McDonald I; Shaw S; Padate B; McNamara C; Kibbler C; Agarwal B
    Br J Anaesth; 2012 Aug; 109(2):291-2. PubMed ID: 22782986
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnologies in haematological malignancies.
    Foà R; Reato G; Guarini A
    Forum (Genova); 1999; 9(3 Suppl 3):54-8. PubMed ID: 10607847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensive Care of Hematological and Oncological Patients: Recent Challenges].
    Beutel G; Schellongowski P; Kiehl M; Kochanek M
    Dtsch Med Wochenschr; 2017 Apr; 142(7):500-505. PubMed ID: 28388745
    [No Abstract]   [Full Text] [Related]  

  • 13. The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation.
    Neumann F; Lobitz O; Fenk R; Bruns I; Köstering M; Steiner S; Hennersdorf M; Kelm M; Strauer BE; Germing U; Hinke A; Haas R; Kobbe G
    Ann Hematol; 2008 Apr; 87(4):299-304. PubMed ID: 18219487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of haematology patients admitted to the intensive care unit.
    McCaughey C; Blackwood B; Glackin M; Brady M; McMullin MF
    Nurs Crit Care; 2013 Jul; 18(4):193-9. PubMed ID: 23782113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practices concerning central venous catheters in haematological patients.
    Boersma RS; Schouten HC
    Eur J Oncol Nurs; 2010 Jul; 14(3):200-4. PubMed ID: 20117964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia.
    Mousset S; Hermann S; Klein SA; Bialleck H; Duchscherer M; Bomke B; Wassmann B; Böhme A; Hoelzer D; Martin H
    Ann Hematol; 2005 Oct; 84(11):734-41. PubMed ID: 15951986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients.
    Sobecks RM; Copelan E; Kalaycio M; Askar M; Rybicki L; Serafino S; Serafin M; Macklis R; Dean R; Pohlman B; Andresen S; Bolwell BJ
    Br J Haematol; 2011 Jan; 152(1):116-9. PubMed ID: 21029069
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality.
    Geerse DA; Span LF; Pinto-Sietsma SJ; van Mook WN
    Eur J Intern Med; 2011 Feb; 22(1):57-61. PubMed ID: 21238895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune therapy in haematological malignancies.
    Tallman MS
    Best Pract Res Clin Haematol; 2006; 19(4):635-6. PubMed ID: 16997173
    [No Abstract]   [Full Text] [Related]  

  • 20. Geriatrics and haematological malignancies: is comprehensive geriatric assessment a useful tool?
    Noens L
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S362-3. PubMed ID: 21944016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.